Victory Capital Management
PRPH

Victory Capital Management’s ProPhase Labs PRPH Stock Holding History

Victory Capital Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,790
Closed -$78.2K – 2618
2023
Q3 		$78.2K Hold
1,790
– – ﹤0.01% 2331
2023
Q2 		$130K Buy
1,790
+369
+26% +$30K ﹤0.01% 2274
2023
Q1 		$108K Buy
+1,421
New +$115K ﹤0.01% 2346
2020
Q2 		– Sell
-180
Closed -$3K – 3080
2020
Q1 		$3K Buy
+180
New +$3.37K ﹤0.01% 3417
2019
Q4 		– Sell
-157
Closed -$3K – 3102
2019
Q3 		$3K Buy
+157
New +$3.12K ﹤0.01% 3573

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management's PRPH Position: Q4 2023 in Review

Victory Capital Management sold out of ProPhase Labs (PRPH) in Q4 2023, closing a stake of 1,790 shares — an estimated $78.2K sold.

Victory Capital Management first reported a position in PRPH in Q3 2019 and held it in 5 quarters. The position peaked at $130K in Q2 2023. 27 funds tracked by Wall St. Rank hold PRPH as of Q4 2023.

  • Victory Capital Management reported no remaining ProPhase Labs position as of Q4 2023 after selling out during the quarter.
  • Victory Capital Management sold 1,790 ProPhase Labs shares in Q4 2023, an estimated $78.2K.
  • Victory Capital Management first reported a position in ProPhase Labs in Q3 2019 and held it in 5 quarters.
  • Victory Capital Management's ProPhase Labs position peaked at $130K in Q2 2023.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.